PreveCeutical Medical Inc (18H) — Financial Flexibility Index
PreveCeutical Medical Inc (18H) has a Financial Flexibility Index of -0.07x as of September 2025. Free cash flow of €-520.46K (operating CF €-520.46K minus capex €0.00) represents 0% of total liabilities (€7.85 Million). Also explore PreveCeutical Medical Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
PreveCeutical Medical Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for PreveCeutical Medical Inc across 9 annual periods. See PreveCeutical Medical Inc balance sheet independence to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for PreveCeutical Medical Inc (2016–2024)
Year-by-year free cash flow to debt coverage for PreveCeutical Medical Inc. For the full company profile including market capitalisation, see PreveCeutical Medical Inc (18H) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.06x | €-424.89K | €-426.69K | €6.86 Million | ▼ -24.3% |
| 2023 | -0.05x | €-296.97K | €-296.97K | €5.96 Million | ▲ +46.7% |
| 2022 | -0.09x | €-450.99K | €-450.99K | €4.82 Million | ▼ -7.4% |
| 2021 | -0.09x | €-371.19K | €-426.39K | €4.27 Million | ▼ -605.6% |
| 2020 | 0.02x | €67.25K | €64.59K | €3.91 Million | ▲ +109.3% |
| 2019 | -0.19x | €-992.61K | €-993.94K | €5.34 Million | ▲ +89.7% |
| 2018 | -1.81x | €-7.57 Million | €-7.57 Million | €4.19 Million | ▼ -28.7% |
| 2017 | -1.40x | €-4.13 Million | €-4.30 Million | €2.94 Million | ▲ +46.2% |
| 2016 | -2.61x | €-1.31 Million | €-1.32 Million | €503.24K | — |